PAREXEL INTERNATIONAL TO PRESENT AT UBS GLOBAL LIFE SCIENCES CONFERENCE
BOSTON, MA, September 20, 2007 – PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the UBS Global Life Sciences Conference at The Grand Hyatt in New York City. Josef von Rickenbach, Chairman and Chief Executive Officer, will be making a formal presentation on PAREXEL at 1:30 p.m. ET on Monday, September 24th. A live webcast of this presentation will be available through the “Investor Relations Webcasts” section of PAREXEL’s web site at www.PAREXEL.com and a replay of the presentation will be available until October 27, 2007.
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 56 locations throughout 43 countries around the world, and has over 6,485 employees. For more information about PAREXEL International visit www.PAREXEL.com.
PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of their respective business and are hereby acknowledged.